References
- Arora S, Javed A, Khar RK, Baboota S. (2005). Floating drug delivery system: a review. AAPS PharmSciTech 6:372–90
- Atyabi F, Sharma H, Mohammad H, Fell J. (1996). In vitro evaluation of a novel gastroretentive formulation based on ion exchange resins. J Control Release 42:105–13
- Caldwell L, Gardner R, Cargill R. (1988a). Drug delivery device which can be retained in the stomach for a controlled period of times. US patents, 30th Aug 1988; 4,767,627
- Caldwell L, Gardner R, Cargill R, et al. (1988b). Drug delivery device which can be retained in the stomach for a controlled period of times. US patents, 5th April 1988; 4,735--804
- Chary R, Rao Y. (2000). Formulation evaluation of methocel K15 M bioadhesive matrix tablet. Drug Dev Ind Pharm 26:901–6
- Chavanpatil MD, Jain P, Chaudhari S, et al. (2006). Novel sustained release, swellable bioadhesive gastroretentive drug delivery system for ofloxacin. Int J Pharm 316:89–92
- Chien Y. (1992). Novel drug delivery systems. 2nd ed. New York (NY): Marcel Dekker Inc
- Cobby J, Mayersohn M. (1974). Walker GC influence of shape factors on kinetics of drug release from matrix tablets. J Pharm Sci 63:732–7
- Desai S, Balton S. (1983). A floating controlled-release drug delivery systems: in vitro--in vivo evaluation. Pharm Res 10:1321--5
- Deshpande A, Rhodes C. (1996). Controlled released drug delivery systems for prolonged gastric residence: an over view. Drug Dev Ind Pharm 22:531–9
- Design Expert@ software version 8.0.3.1 Operation Manual (2010)
- Dollery C. (1999). Therapeutic drugs. Edinburgh, Scotland: Churchill Livingstone
- Dorozynski P, Jachowicz R, Kulinowski P, et al. (2004). The polymers for the preparation of hydrodynamically balanced systems – methods of evaluation. Drug Dev Ind Pharm 30:947–57
- Dyer J, ed. (1997). Applications of absorption spectroscopy of organic compounds. 1st ed. New Delhi: Prentice-Hall of India Pvt. Ltd
- Garg S, Sharma S. (2003). Gastroretntive drug delivery system. Business Brief Pharmatech 2:160–6
- Gershon S, Pader M, Dentrifices I, et al. (1972). Cosmetics science and technology. New York: Wiley-Interscience
- Gibadi M, Feldman S. (1967). Establishment of sink condition in dissolution rate determination: theoretical consideration application to non disintegrating dosage forms. J Pharm Sci 56:1238–42
- Higuchi T. (1963). Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9
- Higuchi T. (1967). Rate of released of medicament from ointment bases containing drugs in suspension. J Pharma Sci 56:1238–42
- Hixson AW, Crowell JH. (1931). Dependence of reaction velocity upon surface agitation. Ind Eng Chem 23:923–93
- Iannuccelli V, Coppi C, Bernabei M, et al. (1998). Air compartment multi unit systems for prolong gastric residence, Part I: Formulation study. Int J Pharm 174:47–54
- International Conference on Harmonization Steering Committee. (1999). Q1A – Stability testing of new drug substances and products
- Kakumanu VK, Arora VK, Bansal AK. (2008). Gastro-retentive dosage form for improving bioavailability of cefpodoxime proxetil in rats. Yakugakud Zasshi Pharm 3:439–45
- Kiortsis S, Kachrimanis K, Broussali T, Malamataris S. (2005). Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. Eur J Pharm Biopharm 59:73–83
- Klausener EA, Lavy E, Friedman M, Hoffman A. (2003). Expandable gastro retentive dosage form. J Control Rel 90:143–62
- Korsmeyer R, Gurny R, Peppas N. (1983). Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15:25–35
- Lachman L, Hebert AL, Joseph LK. (1987). Theory and practice of pharmacy. 3rd ed. Bombay: Varghese Publication House
- Lehr CM. (1994). Bioadhesion technologies for the delivery of peptide and protein drugs to the gastrointestinal tract. Crit Rev Ther Drug Carrier Syst 11:119–60
- Mathews BR. (1999). Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm 25:831–56
- Nokano M, Ogata A. (1984). Examination of natural gums as matrices for sustained release of theophylline. Chem Pharm Bul 32:782--5
- Nur A, Zhang J. (2000). Captopril floating bioadhesive tablets: designed release kinetics. Drug Dev Ind Pharm 26:965–9
- Peppas N. (1985). Analysis of Fickian non-Fickian drug release from polymer. Pharm Acta Helv 60:110–11
- Rouge N, Allemann E, Gex-Fabry M, et al. (1998). Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule an immediate-release tablet containing 25 mg Atenolol. Pharmaceutical Acta Helv 73:81–7
- Saathoff N, Lode H, Neider K, et al. (1992). Pharmacokinetics of Cefpodoxime Proxetil interactions with an antacid an H receptor antagonist. Antimicrob Agents Chemother 36:796--800
- Santus G, Lazzarini G, Bottoni G, et al. (1997). An in vitro in vivo investigation of oral bioadhesive controlled release furosemide formulations. Eur J Pharm Biopharm 44:39–52
- Singh B, Kim K. (2000). Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J Control Rel 63:235–59
- Streobel A, Siepmann J, Bodmeier R. (2006). Gastroretentive drug delivery systems. Expert Opin Drug Deliv 3:217–33
- Todd WM. (1994). Cefpodoxime proxetil: a comprehensive review. Int J Antimicrob Agents 4:37–62
- Wagner J. (1969). Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets, capsules. J Pharm Sci 58:1253–7
- Whitehead L, Fell J, Collet T, et al. (1998). Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J Control Rel 55:3–12